[HTML][HTML] Lessons in PROTAC design from selective degradation with a promiscuous warhead
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
[引用][C] Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
DP Bondeson, BE Smith, GM Burslem… - Cell Chemical …, 2018 - cir.nii.ac.jp
[PDF][PDF] Lessons in PROTAC design from selective degradation with a promiscuous warhead
DP Bondeson, BE Smith, GM Burslem, AD Buhimschi… - researchgate.net
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule Proteolysis Targeting Chimera …
report a previously understudied benefit of small molecule Proteolysis Targeting Chimera …
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
DP Bondeson, BE Smith, GM Burslem… - Cell Chemical …, 2017 - europepmc.org
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule Pro teolysis T argeting C himera …
report a previously understudied benefit of small molecule Pro teolysis T argeting C himera …
[HTML][HTML] Lessons in PROTAC design from selective degradation with a promiscuous warhead
DP Bondeson, BE Smith, GM Burslem… - Cell chemical …, 2018 - ncbi.nlm.nih.gov
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule Pro teolysis T argeting C himera …
report a previously understudied benefit of small molecule Pro teolysis T argeting C himera …
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
DP Bondeson, BE Smith, GM Burslem… - Cell chemical …, 2018 - pubmed.ncbi.nlm.nih.gov
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
DP Bondeson, BE Smith, GM Burslem, AD Buhimschi… - 2018 - hero.epa.gov
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
[HTML][HTML] Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
DP Bondeson, BE Smith, GM Burslem… - Cell Chemical …, 2018 - cell.com
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
[HTML][HTML] Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
DP Bondeson, BE Smith, GM Burslem… - Cell Chemical …, 2018 - Elsevier
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
report a previously understudied benefit of small molecule proteolysis-targeting chimeras …
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
DP Bondeson, BE Smith, GM Burslem… - Cell Chemical …, 2017 - europepmc.org
Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we
report a previously understudied benefit of small molecule Pro teolysis T argeting C himera …
report a previously understudied benefit of small molecule Pro teolysis T argeting C himera …